vs
Side-by-side financial comparison of LifeMD, Inc. (LFMD) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
SBC Medical Group Holdings Inc is the larger business by last-quarter revenue ($39.6M vs $7.1M, roughly 5.6× LifeMD, Inc.). LifeMD, Inc. runs the higher net margin — 282.0% vs 35.9%, a 246.1% gap on every dollar of revenue. On growth, LifeMD, Inc. posted the faster year-over-year revenue change (5.0% vs -10.9%). SBC Medical Group Holdings Inc produced more free cash flow last quarter ($51.2M vs $-3.4M). Over the past eight quarters, SBC Medical Group Holdings Inc's revenue compounded faster (-15.0% CAGR vs -60.0%).
SBI Life Insurance Company Limited is an Indian life insurance company. It was started as a joint venture between State Bank of India (SBI) and French financial institution BNP Paribas Cardif.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
LFMD vs SBC — Head-to-Head
Income Statement — Q4 2025 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $7.1M | $39.6M |
| Net Profit | $20.0M | $14.2M |
| Gross Margin | 40.2% | 73.1% |
| Operating Margin | -87.9% | 32.5% |
| Net Margin | 282.0% | 35.9% |
| Revenue YoY | 5.0% | -10.9% |
| Net Profit YoY | 742.5% | 117.2% |
| EPS (diluted) | — | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $7.1M | $39.6M | ||
| Q3 25 | $60.2M | $43.4M | ||
| Q2 25 | $62.7M | $43.4M | ||
| Q1 25 | $64.1M | $47.3M | ||
| Q4 24 | $6.7M | $44.4M | ||
| Q3 24 | $53.3M | $53.1M | ||
| Q2 24 | $50.7M | $53.1M | ||
| Q1 24 | $44.1M | $54.8M |
| Q4 25 | $20.0M | $14.2M | ||
| Q3 25 | $-3.8M | $12.8M | ||
| Q2 25 | $-1.6M | $2.5M | ||
| Q1 25 | $-183.8K | $21.5M | ||
| Q4 24 | $-3.1M | $6.5M | ||
| Q3 24 | $-4.7M | $2.8M | ||
| Q2 24 | $-6.9M | $18.5M | ||
| Q1 24 | $-6.8M | $18.8M |
| Q4 25 | 40.2% | 73.1% | ||
| Q3 25 | 87.7% | 70.6% | ||
| Q2 25 | 88.1% | 69.2% | ||
| Q1 25 | 86.5% | 79.7% | ||
| Q4 24 | -0.8% | 76.3% | ||
| Q3 24 | 90.6% | 81.5% | ||
| Q2 24 | 90.1% | 74.2% | ||
| Q1 24 | 89.6% | 72.1% |
| Q4 25 | -87.9% | 32.5% | ||
| Q3 25 | -3.3% | 36.6% | ||
| Q2 25 | -0.7% | 33.6% | ||
| Q1 25 | 1.5% | 51.1% | ||
| Q4 24 | -58.2% | 10.6% | ||
| Q3 24 | -7.5% | 26.1% | ||
| Q2 24 | -12.4% | 51.4% | ||
| Q1 24 | -14.0% | 44.6% |
| Q4 25 | 282.0% | 35.9% | ||
| Q3 25 | -6.3% | 29.6% | ||
| Q2 25 | -2.6% | 5.7% | ||
| Q1 25 | -0.3% | 45.4% | ||
| Q4 24 | -46.1% | 14.7% | ||
| Q3 24 | -8.7% | 5.3% | ||
| Q2 24 | -13.6% | 34.8% | ||
| Q1 24 | -15.3% | 34.2% |
| Q4 25 | — | $0.15 | ||
| Q3 25 | — | $0.12 | ||
| Q2 25 | $-0.05 | $0.02 | ||
| Q1 25 | $-0.02 | $0.21 | ||
| Q4 24 | — | $0.05 | ||
| Q3 24 | $-0.13 | $0.03 | ||
| Q2 24 | — | $0.20 | ||
| Q1 24 | — | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $164.1M |
| Total DebtLower is stronger | — | $42.8M |
| Stockholders' EquityBook value | $23.2M | $248.3M |
| Total Assets | $70.4M | $380.4M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $164.1M | ||
| Q3 25 | — | $127.4M | ||
| Q2 25 | $36.2M | $152.7M | ||
| Q1 25 | $34.4M | $132.1M | ||
| Q4 24 | $35.0M | $125.0M | ||
| Q3 24 | $37.6M | $137.4M | ||
| Q2 24 | $35.7M | — | ||
| Q1 24 | $35.1M | — |
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $21.1M | ||
| Q2 25 | $15.9M | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $23.2M | $248.3M | ||
| Q3 25 | $1.3M | $248.0M | ||
| Q2 25 | $-1.8M | $244.6M | ||
| Q1 25 | $-2.3M | $226.4M | ||
| Q4 24 | $-9.1M | $195.1M | ||
| Q3 24 | $-7.7M | $205.0M | ||
| Q2 24 | $-4.2M | $8.8M | ||
| Q1 24 | $-845.3K | $9.0M |
| Q4 25 | $70.4M | $380.4M | ||
| Q3 25 | $66.0M | $321.4M | ||
| Q2 25 | $73.6M | $315.3M | ||
| Q1 25 | $73.6M | $284.6M | ||
| Q4 24 | $76.1M | $266.1M | ||
| Q3 24 | $72.6M | $296.5M | ||
| Q2 24 | $63.8M | $19.5M | ||
| Q1 24 | $61.5M | $19.8M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-3.3M | $52.0M |
| Free Cash FlowOCF − Capex | $-3.4M | $51.2M |
| FCF MarginFCF / Revenue | -48.5% | 129.3% |
| Capex IntensityCapex / Revenue | 2.2% | 2.0% |
| Cash ConversionOCF / Net Profit | -0.16× | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-3.3M | $52.0M | ||
| Q3 25 | $-147.1K | $-20.9M | ||
| Q2 25 | $8.6M | $-8.3M | ||
| Q1 25 | $3.1M | $1.9M | ||
| Q4 24 | $1.1M | $-7.3M | ||
| Q3 24 | $6.7M | $5.0M | ||
| Q2 24 | $4.5M | $19.2M | ||
| Q1 24 | $5.2M | $3.7M |
| Q4 25 | $-3.4M | $51.2M | ||
| Q3 25 | $-944.4K | $-20.9M | ||
| Q2 25 | $7.8M | $-8.6M | ||
| Q1 25 | $2.9M | $1.7M | ||
| Q4 24 | $875.4K | $-7.9M | ||
| Q3 24 | $6.3M | $4.6M | ||
| Q2 24 | $3.9M | $18.3M | ||
| Q1 24 | $5.0M | $3.0M |
| Q4 25 | -48.5% | 129.3% | ||
| Q3 25 | -1.6% | -48.3% | ||
| Q2 25 | 12.5% | -19.9% | ||
| Q1 25 | 4.6% | 3.5% | ||
| Q4 24 | 13.0% | -17.8% | ||
| Q3 24 | 11.7% | 8.7% | ||
| Q2 24 | 7.7% | 34.5% | ||
| Q1 24 | 11.4% | 5.4% |
| Q4 25 | 2.2% | 2.0% | ||
| Q3 25 | 1.3% | 0.1% | ||
| Q2 25 | 1.3% | 0.7% | ||
| Q1 25 | 0.2% | 0.5% | ||
| Q4 24 | 2.9% | 1.3% | ||
| Q3 24 | 0.8% | 0.8% | ||
| Q2 24 | 1.3% | 1.6% | ||
| Q1 24 | 0.4% | 1.3% |
| Q4 25 | -0.16× | 3.66× | ||
| Q3 25 | — | -1.63× | ||
| Q2 25 | — | -3.39× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | -1.12× | ||
| Q3 24 | — | 1.77× | ||
| Q2 24 | — | 1.04× | ||
| Q1 24 | — | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFMD
Segment breakdown not available.
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
